Valuation: DexCom, Inc.

Market Cap 28.39B 24.9B 22.99B 21.24B 40.26B 2,718B 41.07B 276B 107B 1,330B 107B 104B 4,618B P/E 2026 *
30.1x
P/E 2027 * 25.2x
Enterprise Value 27.98B 24.54B 22.66B 20.94B 39.69B 2,679B 40.48B 272B 106B 1,311B 105B 103B 4,552B EV / Sales 2026 *
5.36x
EV / Sales 2027 * 4.67x
Free-Float
93.34%
Yield 2026 *
-
Yield 2027 * -
1 day+0.23%
1 week+7.07%
Current month+9.47%
1 month-3.77%
3 months+12.05%
6 months+7.75%
Current year+11.09%
1 week 69.14
Extreme 69.14
74.01
1 month 67.3
Extreme 67.3
78.91
Current year 56.72
Extreme 56.72
78.91
1 year 54.11
Extreme 54.11
89.98
3 years 54.11
Extreme 54.11
142
5 years 54.11
Extreme 54.11
164.86
10 years 10.66
Extreme 10.655
164.86
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Date Insider Type Main position Quantity % Market Cap.
15/06Sell

Director

-4,000 0.0010%
15/06Sell

General Counsel

-1,700 0.0004%
04/06Sell

Executive/Senior Manager

-4,911 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
+0.24%+7.07%-11.97%-43.55% 28.39B
-0.38%+3.50%-28.46%-10.85% 167B
-2.05%+3.75%-7.24%-4.95% 107B
+1.26%+7.04%+3.59%+60.10% 59.24B
-6.77%-7.86%+44.51%+46.55% 52.99B
-3.07%-0.93%-13.25%-41.18% 43.07B
-5.29%-1.99% - - 36.37B
-0.87%-3.28%+60.12%-6.43% 25.16B
-2.04%+1.90%-7.08%+5.37% 21.17B
-2.35%-0.84%-9.49%-5.62% 20.99B
Average -2.13%+4.63%+3.42%-0.06% 56.16B
Weighted average by Cap. -1.77%+5.14%-5.15%+0.97%

Financials

2026 *2027 *
Net sales 5.22B 4.58B 4.23B 3.91B 7.41B 500B 7.56B 50.86B 19.76B 245B 19.62B 19.19B 850B 5.83B 5.11B 4.72B 4.36B 8.26B 558B 8.43B 56.71B 22.03B 273B 21.88B 21.4B 948B
Net income 963M 844M 779M 720M 1.37B 92.17B 1.39B 9.37B 3.64B 45.1B 3.61B 3.54B 157B 1.16B 1.02B 937M 866M 1.64B 111B 1.67B 11.27B 4.38B 54.25B 4.35B 4.25B 188B
Net Debt -405M -355M -328M -303M -574M -38.78B -586M -3.94B -1.53B -18.98B -1.52B -1.49B -65.88B -1.21B -1.06B -981M -906M -1.72B -116B -1.75B -11.79B -4.58B -56.76B -4.55B -4.45B -197B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
09/07/26 USD 73.64 +0.10% 2,111,981
07/07/26 USD 73.57 +1.64% 5,569,382
06/07/26 USD 72.38 +1.59% 4,621,632
02/07/26 USD 71.25 +3.47% 3,299,278
01/07/26 USD 68.86 +2.24% 4,793,643
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
73.57USD
Average target price
85.24USD
Spread / Average Target
+15.86%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DXCM Stock